News

The results of the TRIO 018 Clinical Trial indicated that the combination of Investigational Agent and Letrozole demonstrated clinical benefit in Advanced ER-positive Breast Cancer.

ICORG’s office has turned BLUE for the entire month of November in support of Movember.
 

ICORG’s contribution to the development of an important new drug (PD 0332991) has been recognised in an oral presentation to be given at the San Antonio Breast Cancer Symposium in December 2012.

October is Breast Cancer Awareness month and here at ICORG we are doing our bit by illuminating our office PINK every evening for the entire month.

Ireland is well placed thanks to its national cancer research organisation – ICORG a non-profit cancer research expert group who have been working for 15 years to put Ireland on the international cancer research map and thankfully have succeeded in securing a role for Ireland in some of the most important new international research currently underway in cancer. This communication will describe five breakthrough treatments that are currently or soon to be available in Ireland through an ICORG clinical trial. Today ICORG has 58 clinical research studies open, many of these at all of Ireland’s cancer treating centres.

IPPOSI (Partnership between Patient Organisations, Science and Industry) have just launched information leaflets about taking part in Clinical Trials

Results of the Velcade Mesothelioma (ICORG 05-10) Study have now been published in the Journal of Thoracic Oncology (September 2012 – Volume 7 – Issue 9)

Congratulations to Dr Anne Horgan and the all of the team in Waterford Regional Hospital on the accrual of the first ICORG patient to this important study on the 27th August.